MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Pilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders

Not Applicable

Completed

Conditions: Transcranial Magnetic Stimulation
Bipolar Disorder

Interventions: Device: Transcranial Magnetic Stimulation (TMS)

First Posted Date: 2018-08-09

Last Posted Date: 2025-02-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 15

Registration Number: NCT03622749

Locations: 🇺🇸
Martinos Center for Biomedical Imaging, Charlestown, Massachusetts, United States

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

Phase 4

Completed

Conditions: Smoking, Tobacco

Interventions: Behavioral: Counseling
Drug: Nicotine patch
Behavioral: Community Resource

First Posted Date: 2018-08-02

Last Posted Date: 2024-10-28

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 642

Registration Number: NCT03611881

Locations: 🇺🇸
Salem Hospital, Salem, Massachusetts, United States
🇺🇸
Newton-Wellesley Hospital, Newton, Massachusetts, United States
🇺🇸
Martha's Vineyard Hospital, Oak Bluffs, Massachusetts, United States

and more 3 locations

Proactive Population Health Strategy to Offer Tobacco Dependence Treatment to Smokers

Not Applicable

Completed

Conditions: Smoking, Tobacco

Interventions: Behavioral: Usual Care
Behavioral: External Community Referral
Behavioral: Internal Care Coordination

First Posted Date: 2018-08-02

Last Posted Date: 2018-08-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 234

Registration Number: NCT03612895

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

EEG Study of IV Methylphenidate-Induced Emergence From Propofol Sedation

Phase 1

Withdrawn

Conditions: Anesthesia

Interventions: Drug: Propofol
Drug: IV Methylphenidate

First Posted Date: 2018-08-01

Last Posted Date: 2020-02-21

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT03610282

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Post-Discharge Smoking Cessation Strategies: Helping HAND 4

Phase 4

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Transitional Tobacco Care Management (TTCM)
Behavioral: eReferral to State Tobacco Quitline (QL)
Drug: Nicotine replacement therapy

First Posted Date: 2018-07-27

Last Posted Date: 2022-05-05

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1416

Registration Number: NCT03603496

Locations: 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

Early Phase 1

Recruiting

Conditions: Dyspepsia
Gastroparesis

Interventions: Device: taVNS

First Posted Date: 2018-07-27

Last Posted Date: 2025-05-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 65

Registration Number: NCT03603730

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Collection of Breath and Sweat to Identify Indicators of Hypoglycemia

Completed

Conditions: Type 1 Diabetes Mellitus

First Posted Date: 2018-07-26

Last Posted Date: 2022-03-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 18

Registration Number: NCT03600116

Locations: 🇺🇸
Massachusetts General Hospital (MGH) Diabetes Research Center, Boston, Massachusetts, United States

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Drug: Topical Calcipotriene Ointment
Other: Topical Vaseline

First Posted Date: 2018-07-23

Last Posted Date: 2025-05-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 43

Registration Number: NCT03596073

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Phase 2

Terminated

Conditions: Heparin-induced Thrombocytopenia and Thrombosis
Heparin-induced Thrombocytopenia

Interventions: Drug: Apixaban

First Posted Date: 2018-07-20

Last Posted Date: 2020-12-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT03594045

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Brigham and Women Hospital, Boston, Massachusetts, United States

Vagus Nerve Stimulation and Stress Reduction Training for Migraine

Not Applicable

Conditions: Migraine

Interventions: Behavioral: Stress Reduction Training A
Device: active tVNS
Behavioral: Stress Reduction Training B
Device: sham tVNS

First Posted Date: 2018-07-19

Last Posted Date: 2022-04-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 150

Registration Number: NCT03592329

Locations: 🇺🇸
Anthinoula A. Martinos Center, Charlestown, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy